NLGIA
BMY icon

Nippon Life Global Investors Americas’s Bristol-Myers Squibb BMY Stock Holding History

Nippon Life Global Investors Americas’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-78,970
Closed -$6.08M – 130
2022
Q2 		$6.08M Buy
+78,970
New +$6.01M 0.39% 75
2020
Q1 		– Sell
-85,070
Closed -$5.46M – 138
2019
Q4 		$5.46M Sell
85,070
-5,100
-6% -$292K 0.37% 76
2019
Q3 		$4.57M Sell
90,170
-18,030
-17% -$847K 0.34% 78
2019
Q2 		$4.91M Buy
108,200
+19,710
+22% +$918K 0.37% 76
2019
Q1 		$4.22M Hold
88,490
– – 0.34% 84
2018
Q4 		$4.6M Hold
88,490
– – 0.4% 73
2018
Q3 		$5.49M Hold
88,490
– – 0.42% 68
2018
Q2 		$4.9M Sell
88,490
-33,020
-27% -$1.78M 0.39% 75
2018
Q1 		$7.69M Sell
121,510
-201,760
-62% -$13M 0.63% 52
2017
Q4 		$19.8M Buy
323,270
+9,230
+3% +$577K 1.58% 14
2017
Q3 		$20M Hold
314,040
– – 1.71% 14
2017
Q2 		$17.5M Hold
314,040
– – 1.5% 14
2017
Q1 		$17.1M Buy
314,040
+7,950
+3% +$436K 1.52% 13
2016
Q4 		$17.9M Sell
306,090
-20,950
-6% -$1.15M 1.65% 11
2016
Q3 		$17.6M Buy
327,040
+42,980
+15% +$2.76M 1.66% 12
2016
Q2 		$20.9M Sell
284,060
-12,220
-4% -$863K 2% 7
2016
Q1 		$18.9M Buy
296,280
+42,150
+17% +$2.66M 1.8% 11
2015
Q4 		$17.5M Buy
254,130
+65,700
+35% +$4.34M 1.64% 11
2015
Q3 		$11.2M Buy
188,430
+12,060
+7% +$765K 1.12% 36
2015
Q2 		$11.7M Buy
176,370
+16,510
+10% +$1.09M 1.06% 36
2015
Q1 		$10.3M Sell
159,860
-28,840
-15% -$1.81M 0.94% 40
2014
Q4 		$11.1M Sell
188,700
-54,260
-22% -$3.06M 1.02% 36
2014
Q3 		$12.4M Buy
242,960
+51,490
+27% +$2.57M 1.17% 26
2014
Q2 		$9.29M Buy
191,470
+116,950
+157% +$5.76M 0.87% 49
2014
Q1 		$3.87M Sell
74,520
-21,090
-22% -$1.12M 0.38% 90
2013
Q4 		$5.08M Buy
95,610
+54,880
+135% +$2.8M 0.5% 85
2013
Q3 		$1.89M Buy
+40,730
New +$1.79M 0.2% 117

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nippon Life Global Investors Americas's BMY Position: Q3 2022 in Review

Nippon Life Global Investors Americas sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 78,970 shares — an estimated $6.08M sold.

Nippon Life Global Investors Americas first reported a position in BMY in Q3 2013 and held it in 27 quarters. The position peaked at $20.9M in Q2 2016. 2,471 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Nippon Life Global Investors Americas reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 78,970 Bristol-Myers Squibb shares in Q3 2022, an estimated $6.08M.
  • Nippon Life Global Investors Americas first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 27 quarters.
  • Nippon Life Global Investors Americas's Bristol-Myers Squibb position peaked at $20.9M in Q2 2016.
  • 2,471 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Nippon Life Global Investors Americas's 13F filing for Q3 2022, filed 14 Nov 2022.